Vertebroplasty needle market projected to reach $1.95 billion by 2030

The global vertebroplasty needle market is projected to grow from $1.12 billion in 2025 to $1.95 billion by 2030, representing a compound annual growth rate (CAGR) of 11.6%. This growth is primarily driven by an increase in spinal injuries and a rapidly aging global population.

Vertebroplasty needles are specialized medical instruments used in minimally invasive procedures to treat vertebral compression fractures caused by osteoporosis or trauma. These devices allow for the injection of bone cement into fractured vertebrae under fluoroscopic or CT guidance to stabilize the bone and alleviate pain.

North America is expected to remain the largest market in 2025, while the Asia-Pacific region is forecasted to be the fastest-growing market during the prediction period. Key industry players include Medtronic, Stryker, DePuy Synthes, Cook Medical, and Merit Medical Systems.